(Q45145247)

English

Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.

scientific article published on 18 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

Ville-Petteri Mäkinen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Mika Ala-Korpela

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

P Soininen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

A J Kangas

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

C Forsblom

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

N Tolonen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

J Viikari

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

O T Raitakari

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Savolainen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

P-H Groop

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Finnish Diabetic Nephropathy Study Group

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

0 references

publication date

18 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

273

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

383-395

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Serum Lipids and Lipoproteins in Insulin-treated Diabetes: Demonstration of Increased High Density Lipoprotein Concentrations

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Serum lipids and the progression of nephropathy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipid disorders in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 Diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Triglycerides as vascular risk factors: new epidemiologic insights

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Metabonomic, transcriptomic, and genomic variation of a population cohort

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study).

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Causes of dysregulation of lipid metabolism in chronic renal failure

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

An update on the lipid nephrotoxicity hypothesis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Focal and segmental glomerulosclerosis: analogies to atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Statins for improving renal outcomes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Meta-analysis: the effect of statins on albuminuria

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

The anti inflammatory effects of high density lipoproteins

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

High-density lipoprotein heterogeneity and function in reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Lipid and lipoprotein metabolism in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Genome-wide association study identifies multiple loci influencing human serum metabolite levels

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12026

21 January 2018

Identifiers

10.1111/JOIM.12026

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279644%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45145247&oldid=1836087181"